Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Flowsom: An R-Based Evaluation Strategy for Flow Cytometry-Based Measurable Residual Disease (MRD) Diagnostics in Acute Myeloid Leukemia (AML)

Veit Bücklein, MD, Alexandra Stein, Benjamin Tast, PhD, Thomas Koehnke, MD, Karsten Spiekermann, MD, Francis Lacombe, MD PhD, Marion Subklewe, MD

Blood (2019) 134 (Supplement_1): 4656.

https://doi.org/10.1182/blood-2019-129866

Published: 2019

Journal Articles

New Concepts of Flow Cytometry Analysis in Oncohematology: Application to Diagnosis and Follow up (Minimal Residual Disease) in AML, ALL and MDS

Francis Lacombe, MD PhD, Benoït Dupont, Nicolas Lechevalier, PharmD, Jean-Philippe Vial, MD, Arnaud Pigneux, MD PhD, Marie C Bene, PharmSciD, PhD

Blood (2017) 130 (Supplement 1): 1421.

https://doi.org/10.1182/blood.V130.Suppl_1.1421.1421

Published: 2017

Journal Articles

Assessment of Peripheral Blood (PB) Blast Decrease Rate by Multiparameter Flow Cytometry: A New Prognostic Factor in Acute Myeloblastic Leukaemia (AML). A Goelams Study.

Francis Lacombe, MD, PhD, Christine Arnoulet, MD,PhD, Marc Maynadie, MD,PhD, Arnaud Pigneux, MD,PhD, Norbert Vey, MD, Olivier Casasnovas, MD, Francis Witz, MD, Marie C. Bene, PharmsSciD,PhD

Blood (2006) 108 (11): 1892.

https://doi.org/10.1182/blood.V108.11.1892.1892

Published: 2006

Journal Articles

Proteasome Inhibition Sensitizes Leukemic Cells to Anthracyclin-Induced Apoptosis by Increasing the Expression of Bim and Bax Pro-Apoptotic Proteins.

Arnaud Pigneux, MD, François X. Mahon, MD, PhD, François Moreau-Gaudry, PhD, Marie L. Néré, Francis Lacombe, MD, PhD, Josy Reiffers, MD, Vincent Praloran, MD, Francis Belloc, PhD

Blood (2005) 106 (11): 2487.

https://doi.org/10.1182/blood.V106.11.2487.2487

Published: 2005

Journal Articles

Bim-EL, Is Sensitive to Proteasome Degradation and Contributes to Inducing Apoptosis after In Vitro Imatinib Mesylate Treatment of BCR-ABL Positive Cells.

Francis Belloc, PhD, Catherine Boyer, Francis Lacombe, MD, PhD, Vincent Praloran, MD, François-Xavier Mahon, MD, PhD

Blood (2004) 104 (11): 4676.

https://doi.org/10.1182/blood.V104.11.4676.4676

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Flowsom: An R-Based Evaluation Strategy for Flow Cytometry-Based Measurable Residual Disease (MRD) Diagnostics in Acute Myeloid Leukemia (AML)

New Concepts of Flow Cytometry Analysis in Oncohematology: Application to Diagnosis and Follow up (Minimal Residual Disease) in AML, ALL and MDS

Assessment of Peripheral Blood (PB) Blast Decrease Rate by Multiparameter Flow Cytometry: A New Prognostic Factor in Acute Myeloblastic Leukaemia (AML). A Goelams Study.

Proteasome Inhibition Sensitizes Leukemic Cells to Anthracyclin-Induced Apoptosis by Increasing the Expression of Bim and Bax Pro-Apoptotic Proteins.

Bim-EL, Is Sensitive to Proteasome Degradation and Contributes to Inducing Apoptosis after In Vitro Imatinib Mesylate Treatment of BCR-ABL Positive Cells.

Email alerts

ASH Publications

American Society of Hematology

Update search

Flowsom: An R-Based Evaluation Strategy for Flow Cytometry-Based Measurable Residual Disease (MRD) Diagnostics in Acute Myeloid Leukemia (AML)

New Concepts of Flow Cytometry Analysis in Oncohematology: Application to Diagnosis and Follow up (Minimal Residual Disease) in AML, ALL and MDS

Assessment of Peripheral Blood (PB) Blast Decrease Rate by Multiparameter Flow Cytometry: A New Prognostic Factor in Acute Myeloblastic Leukaemia (AML). A Goelams Study.

Proteasome Inhibition Sensitizes Leukemic Cells to Anthracyclin-Induced Apoptosis by Increasing the Expression of Bim and Bax Pro-Apoptotic Proteins.

Bim-EL, Is Sensitive to Proteasome Degradation and Contributes to Inducing Apoptosis after In Vitro Imatinib Mesylate Treatment of BCR-ABL Positive Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only